Walter Singleton
Keine laufenden Positionen mehr
Profil
Walter Singleton has been Chief Medical Officer of ImaRx Therapeutics, Inc. since May, 2006.
Prior to that, he was Vice President of Regulatory Affairs for Inovio, Inc. from October, 2004 to July, 2005.
Previously, he was Vice President of Development for Chugai Co. Ltd.
from October, 2000 to December, 2003.
Dr. Singleton received a BM degree, a BCh degree and a Master's Degree in Animal Physiology from Oxford University.
Ehemalige bekannte Positionen von Walter Singleton
| Unternehmen | Position | Ende |
|---|---|---|
| Inovio, Inc. | General Counsel | 01.07.2005 |
Chugai Co., Ltd.
 Chugai Co., Ltd. Auto Parts: OEMProducer Manufacturing Chugai Co., Ltd. has engages in manufacturing and distributing of automotive parts and electronic components and equipment. The company was founded in 1948 and is headquartered in Aichi, Japan. | Corporate Officer/Principal | 01.12.2003 |
ImaRx Therapeutics, Inc.
 ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Walter Singleton
| University of Oxford | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
ImaRx Therapeutics, Inc.
ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Health Technology |
| Inovio, Inc. | |
Chugai Co., Ltd.
Chugai Co., Ltd. Auto Parts: OEMProducer Manufacturing Chugai Co., Ltd. has engages in manufacturing and distributing of automotive parts and electronic components and equipment. The company was founded in 1948 and is headquartered in Aichi, Japan. | Producer Manufacturing |
